Navigation Links
Breast Cancer Clinical Results Show Test Can Differentiate Normal, Early and Later Stage Cancers
Date:2/5/2009

TORONTO, Feb. 5 /PRNewswire-FirstCall/ - Predictive medicine company PreMD Inc. (TSX: PMD; PREMF.pk) today announced that its recently completed clinical trial data was presented at the 4th Annual Academic Surgical Congress in Fort Myers, FL. The peer reviewed data was presented by Dr. Anees B. Chagpar from the University of Louisville. The presentation entitled, "Quantitative Galactose Oxidase Schiff's reaction in Nipple Aspirate Fluid may distinguish women with or without Breast Cancer" concluded by stating that "GOS reactivity as measured by adjusted chroma values are significantly different between normal patients, those with Ductal Carcenoma In Situ and those with invasive cancer" and that "these results warrant further investigation".

"We are extremely pleased that the data was supportive of this novel breast cancer test and that the investigators feel that there is a need to continue to explore the potential of this test, and thus confirm that there is value to the technology. However, it is clear that funding to develop these potentially valuable tests is not readily available today and as such, work on this test will cease, at least for a while," said Dr. Brent Norton, President and CEO of PreMD Inc. "We are hopeful that one or more interested parties' steps forward to invest in or acquire this technology as it has the potential to advance the fight against this disease," he added.

About PreMD Inc.

PreMD Inc. is a leader in predictive medicine, dedicated to developing rapid, non-invasive tests for the early detection of life-threatening diseases. PreMD's cardiovascular products include PREVU* POC and PREVU* LT, both non-invasive skin cholesterol tests. The Company's cancer tests include ColorectAlertTM, LungAlertTM and a breast cancer test. PreMD's head office is located in Toronto, Ontario and its research and product development facility is at McMaster University in Hamilton, Ontario.
'/>"/>

SOURCE PreMD Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
7. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
8. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
11. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 27, 2015 The Bio-Process Systems Alliance ... Annual International Single-Use Summit (ISUS 2015) will be ... , with a primary focus on the promises ... From technical topics to business and regulatory presentations, ... the emergence of the single-use industry as the "go-to" ...
(Date:5/27/2015)...  Foundation Health Care  (FDNH), which owns and operates ... today it will present at the LD Micro Invitational ... Sunset Boulevard Hotel, Los Angeles, CA. ... nd at 3:00pm and will also be available ... contact LD Micro. For more information about the conference, ...
(Date:5/27/2015)... REDWOOD CITY, Calif. , May 27, 2015  Genomic ... Brad Cole , Chief Operating Officer and Chief Financial Officer, ... New York City on Monday, June ... access the live and subsequently archived webcast of the presentation, ... site at http://investor.genomichealth.com .  Please connect to the web ...
Breaking Medicine Technology:BPSA's 5th Annual Summit to Provide '2020 Vision' for Single-Use Technologies 2BPSA's 5th Annual Summit to Provide '2020 Vision' for Single-Use Technologies 3Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3
... Feb. 28, 2011 The staffs of Chiltern International ... Spectratox Limited, celebrate the 25 year mark of their ... Early Phase and Spectratox have worked together using a ... study method for the assessment of drug phototoxicity. The ...
... for Ethical Imaging (CEI), a grassroots coalition with the ... supporting House Bill 1809, sponsored by Representative Senfronia Thompson. ... in healthcare costs in the state while ensuring patient ... medical professionals, members of the business community interested in ...
Cached Medicine Technology:Chiltern - Spectratox Drug Photoxicity Collaboration Celebrates 25 Years 2Chiltern - Spectratox Drug Photoxicity Collaboration Celebrates 25 Years 3Coalition for Ethical Imaging Advocates Diagnostic Imaging Reform in the 82nd Texas Legislature 2Coalition for Ethical Imaging Advocates Diagnostic Imaging Reform in the 82nd Texas Legislature 3
(Date:5/27/2015)... (PRWEB) May 27, 2015 Dr. Omar ... based in Stamford, CT has been selected as part ... first physicians nationwide (and the only physician in Connecticut) ... which allows for the removal of submental fat (double ... no recovery time, no surgery and minimal risks. Dr. ...
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ... for enterprise organizations, announced today that SanMar Corporation ... its time, attendance and point tracking processes for ... United States. , Family-owned since 1971, Seattle-based ... retail, private label, and mill brands. SanMar supplies ...
(Date:5/27/2015)... In support of a new ... the Journal of American Geriatrics Society about the link ... Bedford Commons OB-GYN P.A . is reiterating the nutritional ... , To examine the relationship between diet soda ... Longitudinal Study of Aging (SALSA) tracked the soda consumption ...
(Date:5/27/2015)... The Case Management Society of ... provide CMSA's Career and Knowledge Pathways educational program ... strengthen the case/care management workforce by offering aptitude ... mutually beneficial agreement provides Medix, a workforce solutions ... in the healthcare, scientific and IT industries, access ...
(Date:5/27/2015)... SAN DIEGO, May 27, 2015 ... the first healthcare provider along the Gulf Coast ... management (CCM). In partnership with MD Revolution, a ... a new program that enables healthcare providers to ... reimbursements. This new, user-friendly program is designed to ...
Breaking Medicine News(10 mins):Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3
... Dec. 16 Pennsylvania, along with 31 other states ... settlement with Airborne Health, Inc., and its owners, over ... containing their Airborne Effervescent Health Formula. Pennsylvania will receive ... Attorney General Tom Corbett said that Airborne Health, ...
... Dec. 16 A study comparing breastfed and formula ... of breastfeeding are greater than the potential risks associated with ... present in breastmilk, according to a report published in the ... , a peer-reviewed journal published by Mary Ann Liebert, ...
... deadly,bacteria in lungs , , TUESDAY, Dec. 16 (HealthDay News) ... in the lungs of cystic fibrosis patients are signaling ... The pigments may enable infectious Pseudomonas aeruginosa ... Massachusetts Institute of Technology (MIT) study. , The ...
... Structural interventions and public safety messages may be the ... the overall safety of New York City subway systems, ... Mailman School of Public Health. Subway safety is important ... mode of transportation, it has the highest fatality rate ...
... Healthcare Management Systems,Inc.(R) (HMS) announced today that it ... system of integrated clinical and financial software. For the,20-bed ... HMS,system reinforces their commitment to providing quality, patient-centered care,for ... Kimball Health Services has some healthcare technology in place ...
... (TSX, FSE: HBP) reports that at its Annual General Meeting held today, shareholders overwhelmingly ... General Meeting Results , , All seven Board ... , , , ... and Chief Executive Officer, Kenneth A. Cawkell ...
Cached Medicine News:Health News:Pennsylvania Attorney General Corbett Announces a Multi-State, $7 Million Settlement With Airborne Health, Inc., Over Charges of Deceptive Advertising 2Health News:Benefits of Breastfeeding Outweigh Risk of Infant Exposure to Environmental Chemicals in Breastmilk 2Health News:Benefits of Breastfeeding Outweigh Risk of Infant Exposure to Environmental Chemicals in Breastmilk 3Health News:Scientists Spot Key to Cystic Fibrosis Infections 2Health News:'Don't drink and ride': Improving subway safety 2Health News:Kimball Health Services Selects HMS to Provide Information Technology Infrastructure 2Health News:Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update 2Health News:Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update 3Health News:Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update 4Health News:Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update 5
Demineralized bone matrix dispensed in a syringe. DBM will be free of foreign matter. Demineralized bone matrix particle size 125 to 850 . Glycerol 70-88% by weight. Calcium content less than 8%....
... Inductive demineralized bone matrix and ... cancellous chips will be free ... matrix particle size is 125 ... particle size is 1 - ...
... Inductive demineralized bone matrix ... and cancellous chips will be ... bone matrix particle size is ... chip particle size is 1 ...
... a centralized O.R. control system that empowers ... giving them better control, better information and ... as future enhancements will mainly require software ... entirely new system. Endoalpha is unique in ...
Medicine Products: